Patient Guide: Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05935358
Status: 🟢 Enrolling Now
Condition: Severe Hemophilia A
Phase: PHASE4

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Dallas, Texas
  • • Zagreb,
  • • Helsinki,
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study - Join Clinical Trial NCTNCT05935358

How to Join This Clinical Trial - NCTNCT05935358

Learn how to participate in this PHASE4 trial studying an investigational therapy for Severe Hemophilia A. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Severe Hemophilia A. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Severe Hemophilia A
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05935358 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Dallas, Texas 75390 - United States

Status: RECRUITING

Clinical Research Site

Zagreb, - Croatia

Status: RECRUITING

Clinical Research Site

Helsinki, - Finland

Status: RECRUITING

Clinical Research Site

Nantes, - France

Status: RECRUITING

Clinical Research Site

Tours, - France

Status: RECRUITING

Clinical Research Site

Berlin, - Germany

Status: RECRUITING

Clinical Research Site

Duisburg, - Germany

Status: RECRUITING

Clinical Research Site

Hamburg, - Germany

Status: RECRUITING

Clinical Research Site

Vellore, Tamil Nadu - India

Status: RECRUITING

Clinical Research Site

Bengaluru, - India

Status: RECRUITING

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Severe Hemophilia A:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships